Anti-SRP myositis: a diagnostic and therapeutic challenge
Early diagnosis of patients with anti-SRP myositis is important to control inflammation and prevent disease progression and complications. To our knowledge, our patient is the youngest case reported in the literature and was successfully treated with rituximab added to conventional therapy.
Authors
- Elif Çelikel (ORCID: https://orcid.org/0000-0003-0129-4410)
- Beril Talim (ORCID: https://orcid.org/0000-0003-2375-7543)
- Nesrin Şenbil (ORCID: https://orcid.org/0000-0002-4143-3553)
- Didem Ardıçlı (ORCID: https://orcid.org/0000-0001-7054-3623)
- Banu Çelikel Acar (ORCID: https://orcid.org/0000-0002-1808-3655)
- Merve Cansu Polat (ORCID: https://orcid.org/0000-0003-3279-8435)
Institutions
- University of Turku (FI)
- University of Health Science (KH)
- Başkent University Hospital (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Hacettepe University (TR)
Publication Details
- Journal
- The Turkish Journal of Pediatrics
- Published
- 2024-12-18
- DOI
- https://doi.org/10.24953/turkjpediatr.2024.4916
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00